WuXi AppTec Co., Ltd. (HKG:2359)

Market Cap	246.63B
Revenue (ttm)	42.45B
Net Income (ttm)	11.99B
Shares Out	n/a
EPS (ttm)	3.48
PE Ratio	20.58
Forward PE	18.08
Dividend	1.43 (1.63%)
Ex-Dividend Date	May 15, 2025

Volume	3,225,665
Average Volume	6,144,415
Open	88.90
Previous Close	89.15
Day's Range	87.90 - 89.85
52-Week Range	28.15 - 91.20
Beta	0.74
RSI	74.81
Earnings Date	Jul 27, 2025

About WuXi AppTec

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2000
• Employees: 39,414
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2359

Financial Performance

In 2024, WuXi AppTec's revenue was 37.92 billion, a decrease of -1.97% compared to the previous year's 38.68 billion. Earnings were 9.45 billion, a decrease of -1.63%.

Financial numbers in CNY